Cargando…

FLT3 inhibitor design using molecular docking based virtual screening for acute myeloid leukemia

Acute Myeloid Leukaemia (AML) is a blood cancer, which affects the red blood cells in the bone marrow. Of the possible proteins that are affected in AML, fms-like tyrosine kinase 3 (FLT3) has long been recognized as a potential therapeutic target as it affects the other signaling pathways and leads...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gokhale, Padmini, Chauhan, Aashish Pratap Singh, Arora, Anushka, Khandekar, Natasha, Nayarisseri, Anuraj, Singh, Sanjeev Kumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Biomedical Informatics 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677903/ https://www.ncbi.nlm.nih.gov/pubmed/31435156 http://dx.doi.org/10.6026/97320630015104

Ejemplares similares

Identification of Potent VEGF Inhibitors for the Clinical Treatment of Glioblastoma, A Virtual Screening Approach
por: Yadav, Mohini, et al.
Publicado: (2019)

Virtual Screening of IL-6 Inhibitors for Idiopathic Arthritis
por: Shukla, Palak, et al.
Publicado: (2019)

Screening, isolation and characterization of biosurfactant producing Bacillus subtilis strain ANSKLAB03
por: Nayarisseri, Anuraj, et al.
Publicado: (2018)

Design of PD-L1 inhibitors for lung cancer
por: Udhwani, Trishang, et al.
Publicado: (2019)

Genome analysis of biosurfactant producing bacterium, Bacillus tequilensis
por: Nayarisseri, Anuraj, et al.
Publicado: (2023)

Identification of High-Affinity Small Molecule Targeting IDH2 for the Clinical Treatment of Acute Myeloid Leukemia
por: Sweta, Jajoriya, et al.
Publicado: (2019)

Structural basis for the in vitro known acyl-depsipeptide 2 (ADEP2) inhibition to Clp 2 protease from Mycobacterium tuberculosis
por: Khandekar, Natasha, et al.
Publicado: (2016)

Design of novel JAK3 Inhibitors towards Rheumatoid Arthritis using molecular docking analysis
por: Jain, Divya, et al.
Publicado: (2019)

Molecular docking based screening of GABA (A) receptor inhibitors from plant derivatives
por: Sahila, Mohammed Marunnan, et al.
Publicado: (2015)

Mutation of NPM1 and FLT3 Genes in Acute Myeloid Leukemia and Their Association with Clinical and Immunophenotypic Features
por: Chauhan, Pradeep Singh, et al.
Publicado: (2013)

FLT3 inhibitors in acute myeloid leukemia
por: Wu, Mei, et al.
Publicado: (2018)

DOCK2 Interacts with FLT3 and Modulates the Survival of FLT3-Expressing Leukemia Cells
por: Wu, Min, et al.
Publicado: (2016)

Molecular docking approaches in identification of High affinity inhibitors of Human SMO receptor
por: Akare, Uday Raj, et al.
Publicado: (2014)

Computer aided identification of sodium channel blockers in the clinical treatment of epilepsy using molecular docking tools
por: Shaheen, Uzma, et al.
Publicado: (2015)

Targeting FLT3 Mutations in Acute Myeloid Leukemia
por: El Fakih, Riad, et al.
Publicado: (2018)

Potential targeting of FLT3 acute myeloid leukemia
por: Ambinder, Alexander J., et al.
Publicado: (2020)

Molecular Docking and Pharmacological Investigations of Rivastigmine-Fluoxetine and Coumarin–Tacrine hybrids against Acetyl Choline Esterase
por: Babitha, Pallikkara Pulikkal, et al.
Publicado: (2015)

Molecular docking analysis of RN18 and VEC5 in A3G-Vif inhibition
por: Sinha, Chanda, et al.
Publicado: (2014)

Structure based virtual screening of ligands to identify cysteinyl leukotriene receptor 1 antagonist
por: Bandaru, Srinivas, et al.
Publicado: (2014)

OTS167 blocks FLT3 translation and synergizes with FLT3 inhibitors in FLT3 mutant acute myeloid leukemia
por: Eisfelder, Bartholomew J., et al.
Publicado: (2021)

The Impact of FLT3 Mutations on the Development of Acute Myeloid Leukemias
por: Testa, Ugo, et al.
Publicado: (2013)

Targeting FLT3 Signaling in Childhood Acute Myeloid Leukemia
por: Sexauer, Amy N., et al.
Publicado: (2017)

Clinical use of FLT3 inhibitors in acute myeloid leukemia
por: Sutamtewagul, Grerk, et al.
Publicado: (2018)

FLT3 inhibitors: clinical potential in acute myeloid leukemia
por: Hospital, Marie-Anne, et al.
Publicado: (2017)

Two myeloid leukemia cases with rare FLT3 fusions
por: Zhang, Haijiao, et al.
Publicado: (2018)

Developments and challenges of FLT3 inhibitors in acute myeloid leukemia
por: Ge, Shuai-Shuai, et al.
Publicado: (2022)

Disrupting autophagy in FLT3-mutant acute myeloid leukemia
por: Grant, Steven
Publicado: (2022)

CPX-351 in FLT3-mutated acute myeloid leukemia
por: Andrews, Claire, et al.
Publicado: (2023)

Screening, Purification and Characterization of Protease Inhibitor from Capsicum frutescens
por: Mohan, Manju, et al.
Publicado: (2018)

Triplet therapy with venetoclax, FLT3 inhibitor and decitabine for FLT3-mutated acute myeloid leukemia
por: Maiti, Abhishek, et al.
Publicado: (2021)

“FLipping” the Story: FLT3-Mutated Acute Myeloid Leukemia and the Evolving Role of FLT3 Inhibitors
por: Knight, Tristan E., et al.
Publicado: (2022)

DOCK2: A novel FLT3/ITD leukemia drug target
por: Wu, Min, et al.
Publicado: (2017)

Venetoclax combines synergistically with FLT3 inhibition to effectively target leukemic cells in FLT3-ITD+ acute myeloid leukemia models
por: Mali, Raghuveer Singh, et al.
Publicado: (2020)

A novel combination regimen of BET and FLT3 inhibition for FLT3-ITD acute myeloid leukemia
por: Lee, Lauren Y., et al.
Publicado: (2021)

Autophagy activation mediates resistance to FLT3 inhibitors in acute myeloid leukemia with FLT3-ITD mutation
por: Xu, Dan, et al.
Publicado: (2022)

Emerging treatment paradigms with FLT3 inhibitors in acute myeloid leukemia
por: Short, Nicholas J., et al.
Publicado: (2019)

Mechanisms Underlying Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia
por: Eguchi, Motoki, et al.
Publicado: (2020)

Gilteritinib: a novel FLT3 inhibitor for acute myeloid leukemia
por: Zhao, Juanjuan, et al.
Publicado: (2019)

Maintenance therapy for FLT3-ITD-mutated acute myeloid leukemia
por: Burchert, Andreas
Publicado: (2021)

FLT3 mutated acute myeloid leukemia: 2021 treatment algorithm
por: Daver, Naval, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qk41k47vclhv35krlslsjnjvut